These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 15507883

  • 1. Omalizumab: efficacy in allergic disease.
    Spector S.
    Panminerva Med; 2004 Jun; 46(2):141-8. PubMed ID: 15507883
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM, Humbert M, Bousquet J, Boulet LP, Hedgecock S, Blogg M, Fox H, Surrey K.
    Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
    [Abstract] [Full Text] [Related]

  • 3. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST, Djukanović R, Casale T, Bousquet J.
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [Abstract] [Full Text] [Related]

  • 4. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D.
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal anti-IgE antibody: a novel therapy for allergic airways disease.
    Berger WE.
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):152-60; quiz 161-2, 208. PubMed ID: 11868919
    [Abstract] [Full Text] [Related]

  • 6. Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody.
    D'Amato G.
    Expert Opin Biol Ther; 2003 Apr; 3(2):371-6. PubMed ID: 12662149
    [Abstract] [Full Text] [Related]

  • 7. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C.
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [Abstract] [Full Text] [Related]

  • 8. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):302-7. PubMed ID: 16464445
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R, Chung KF, Panahloo Z, Blogg M, Ayre G.
    Respir Med; 2008 Oct 08; 102(10):1371-8. PubMed ID: 18657960
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.
    Holgate S, Bousquet J, Wenzel S, Fox H, Liu J, Castellsague J.
    Curr Med Res Opin; 2001 Oct 08; 17(4):233-40. PubMed ID: 11922396
    [Abstract] [Full Text] [Related]

  • 11. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.
    Busse WW, Massanari M, Kianifard F, Geba GP.
    Curr Med Res Opin; 2007 Oct 08; 23(10):2379-86. PubMed ID: 17711616
    [Abstract] [Full Text] [Related]

  • 12. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.
    Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, Fox H, Hedgecock S, Blogg M, Cioppa GD.
    Allergy; 2005 Mar 08; 60(3):302-8. PubMed ID: 15679714
    [Abstract] [Full Text] [Related]

  • 13. Treating moderate-to-severe allergic asthma with anti-IgE monoclonal antibody (omalizumab). An update.
    D'Amato G, Perticone M, Bucchioni E, Salzillo A, D'Amato M, Liccardi G.
    Eur Ann Allergy Clin Immunol; 2010 Aug 08; 42(4):135-40. PubMed ID: 21114196
    [Abstract] [Full Text] [Related]

  • 14. Add-on omalizumab improves day-to-day symptoms in inadequately controlled severe persistent allergic asthma.
    Humbert M, Berger W, Rapatz G, Turk F.
    Allergy; 2008 May 08; 63(5):592-6. PubMed ID: 18355388
    [Abstract] [Full Text] [Related]

  • 15. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
    Dodig S, Richter D, Cepelak I, Benko B.
    Acta Pharm; 2005 Jun 08; 55(2):123-38. PubMed ID: 16179127
    [Abstract] [Full Text] [Related]

  • 16. Omalizumab in the treatment of severe asthma: efficacy and current problems.
    Pelaia G, Renda T, Romeo P, Busceti MT, Maselli R.
    Ther Adv Respir Dis; 2008 Dec 08; 2(6):409-21. PubMed ID: 19124386
    [Abstract] [Full Text] [Related]

  • 17. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L, Sorkness CA.
    Ann Pharmacother; 2007 Sep 08; 41(9):1397-410. PubMed ID: 17698897
    [Abstract] [Full Text] [Related]

  • 18. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE.
    Pharmacol Ther; 2007 Jan 08; 113(1):121-33. PubMed ID: 17000005
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma.
    Ayres JG, Higgins B, Chilvers ER, Ayre G, Blogg M, Fox H.
    Allergy; 2004 Jul 08; 59(7):701-8. PubMed ID: 15180756
    [Abstract] [Full Text] [Related]

  • 20. Omalizumab: a novel therapy for allergic asthma.
    Davis LA.
    Ann Pharmacother; 2004 Jul 08; 38(7-8):1236-42. PubMed ID: 15187202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.